WELL Health Technologies Corp (WELL), the Technology company, was revisited by a Wall Street analyst yesterday. GMP FirstEnergy’s analyst Justin Keywood reiterates their Buy rating on the shares, with a C$2.25 price target.
Keywood has an average return of 21.4% when recommending WELL Health Technologies Corp.
According to TipRanks.com, Keywood is ranked #3939 out of 5575 analysts.
Read also: The Clouds Are Getting Darker for Blackberry (BB) Stock
WELL Health Technologies Corp has an analyst consensus of Strong Buy, with a price target consensus of C$2.01, a 48.9% upside from current levels. In a report released yesterday, Beacon also reiterated a Buy rating on the stock with a C$2.00 price target.
The company has a one-year high of C$1.87 and a one-year low of C$0.36. Currently, WELL Health Technologies Corp has an average volume of 333.4K.
WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities. It operates through Shakti and CYI segments. The Shakti segment focuses on the sale of yoga clothing. The CYI segment involves in the operation of yoga studio. The company was founded by Hamed Shahbazi on November 23, 2010 and is headquartered in Vancouver, Canada.
The company’s shares closed last Wednesday at C$1.32.
